The global market for Poliomyelitis Vaccines was valued at US$ 3283 million in the year 2024 and is projected to reach a revised size of US$ 6961 million by 2031, growing at a CAGR of 11.5% during the forecast period.

Poliomyelitis Vaccines Market

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.

The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2024.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Poliomyelitis Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliomyelitis Vaccines.

The Poliomyelitis Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Poliomyelitis Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Poliomyelitis Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Poliomyelitis Vaccines Market Report

Report Metric	Details
Report Name	Poliomyelitis Vaccines Market
Accounted market size in year	US$ 3283 million
Forecasted market size in 2031	US$ 6961 million
CAGR	11.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	IPV OPV
Segment by Application	Research & Academic Laboratories Pharmaceutical & Biotechnology Companies Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Poliomyelitis Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Poliomyelitis Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Poliomyelitis Vaccines Market growing?

Ans: The Poliomyelitis Vaccines Market witnessing a CAGR of 11.5% during the forecast period 2025-2031.

What is the Poliomyelitis Vaccines Market size in 2031?

Ans: The Poliomyelitis Vaccines Market size in 2031 will be US$ 6961 million.

Who are the main players in the Poliomyelitis Vaccines Market report?

Ans: The main players in the Poliomyelitis Vaccines Market are Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals

What are the Application segmentation covered in the Poliomyelitis Vaccines Market report?

Ans: The Applications covered in the Poliomyelitis Vaccines Market report are Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, Others

What are the Type segmentation covered in the Poliomyelitis Vaccines Market report?

Ans: The Types covered in the Poliomyelitis Vaccines Market report are IPV, OPV

1 Poliomyelitis Vaccines Market Overview

1.1 Product Definition

1.2 Poliomyelitis Vaccines by Type

1.2.1 Global Poliomyelitis Vaccines Market Value Comparison by Type (2024 VS 2031)

1.2.2 IPV

1.2.3 OPV

1.3 Poliomyelitis Vaccines by Application

1.3.1 Global Poliomyelitis Vaccines Market Value by Application (2024 VS 2031)

1.3.2 Research & Academic Laboratories

1.3.3 Pharmaceutical & Biotechnology Companies

1.3.4 Others

1.4 Global Poliomyelitis Vaccines Market Size Estimates and Forecasts

1.4.1 Global Poliomyelitis Vaccines Revenue 2020-2031

1.4.2 Global Poliomyelitis Vaccines Sales 2020-2031

1.4.3 Global Poliomyelitis Vaccines Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Poliomyelitis Vaccines Market Competition by Manufacturers

2.1 Global Poliomyelitis Vaccines Sales Market Share by Manufacturers (2020-2025)

2.2 Global Poliomyelitis Vaccines Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Poliomyelitis Vaccines Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Poliomyelitis Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Poliomyelitis Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Poliomyelitis Vaccines, Product Type & Application

2.7 Global Key Manufacturers of Poliomyelitis Vaccines, Date of Enter into This Industry

2.8 Global Poliomyelitis Vaccines Market Competitive Situation and Trends

2.8.1 Global Poliomyelitis Vaccines Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Poliomyelitis Vaccines Players Market Share by Revenue

2.8.3 Global Poliomyelitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Poliomyelitis Vaccines Market Scenario by Region

3.1 Global Poliomyelitis Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Poliomyelitis Vaccines Sales by Region: 2020-2031

3.2.1 Global Poliomyelitis Vaccines Sales by Region: 2020-2025

3.2.2 Global Poliomyelitis Vaccines Sales by Region: 2026-2031

3.3 Global Poliomyelitis Vaccines Revenue by Region: 2020-2031

3.3.1 Global Poliomyelitis Vaccines Revenue by Region: 2020-2025

3.3.2 Global Poliomyelitis Vaccines Revenue by Region: 2026-2031

3.4 North America Poliomyelitis Vaccines Market Facts & Figures by Country

3.4.1 North America Poliomyelitis Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Poliomyelitis Vaccines Sales by Country (2020-2031)

3.4.3 North America Poliomyelitis Vaccines Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Poliomyelitis Vaccines Market Facts & Figures by Country

3.5.1 Europe Poliomyelitis Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Poliomyelitis Vaccines Sales by Country (2020-2031)

3.5.3 Europe Poliomyelitis Vaccines Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Poliomyelitis Vaccines Market Facts & Figures by Region

3.6.1 Asia Pacific Poliomyelitis Vaccines Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Poliomyelitis Vaccines Sales by Region (2020-2031)

3.6.3 Asia Pacific Poliomyelitis Vaccines Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Poliomyelitis Vaccines Market Facts & Figures by Country

3.7.1 Latin America Poliomyelitis Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Poliomyelitis Vaccines Sales by Country (2020-2031)

3.7.3 Latin America Poliomyelitis Vaccines Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Poliomyelitis Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa Poliomyelitis Vaccines Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Poliomyelitis Vaccines Sales by Country (2020-2031)

3.8.3 Middle East and Africa Poliomyelitis Vaccines Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Poliomyelitis Vaccines Sales by Type (2020-2031)

4.1.1 Global Poliomyelitis Vaccines Sales by Type (2020-2025)

4.1.2 Global Poliomyelitis Vaccines Sales by Type (2026-2031)

4.1.3 Global Poliomyelitis Vaccines Sales Market Share by Type (2020-2031)

4.2 Global Poliomyelitis Vaccines Revenue by Type (2020-2031)

4.2.1 Global Poliomyelitis Vaccines Revenue by Type (2020-2025)

4.2.2 Global Poliomyelitis Vaccines Revenue by Type (2026-2031)

4.2.3 Global Poliomyelitis Vaccines Revenue Market Share by Type (2020-2031)

4.3 Global Poliomyelitis Vaccines Price by Type (2020-2031)

5 Segment by Application

5.1 Global Poliomyelitis Vaccines Sales by Application (2020-2031)

5.1.1 Global Poliomyelitis Vaccines Sales by Application (2020-2025)

5.1.2 Global Poliomyelitis Vaccines Sales by Application (2026-2031)

5.1.3 Global Poliomyelitis Vaccines Sales Market Share by Application (2020-2031)

5.2 Global Poliomyelitis Vaccines Revenue by Application (2020-2031)

5.2.1 Global Poliomyelitis Vaccines Revenue by Application (2020-2025)

5.2.2 Global Poliomyelitis Vaccines Revenue by Application (2026-2031)

5.2.3 Global Poliomyelitis Vaccines Revenue Market Share by Application (2020-2031)

5.3 Global Poliomyelitis Vaccines Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Sanofi

6.1.1 Sanofi Company Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sanofi Poliomyelitis Vaccines Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.2.4 GSK Poliomyelitis Vaccines Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Bibcol

6.3.1 Bibcol Company Information

6.3.2 Bibcol Description and Business Overview

6.3.3 Bibcol Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Bibcol Poliomyelitis Vaccines Product Portfolio

6.3.5 Bibcol Recent Developments/Updates

6.4 Serum Institute

6.4.1 Serum Institute Company Information

6.4.2 Serum Institute Description and Business Overview

6.4.3 Serum Institute Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Serum Institute Poliomyelitis Vaccines Product Portfolio

6.4.5 Serum Institute Recent Developments/Updates

6.5 Tiantan Biological

6.5.1 Tiantan Biological Company Information

6.5.2 Tiantan Biological Description and Business Overview

6.5.3 Tiantan Biological Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Tiantan Biological Poliomyelitis Vaccines Product Portfolio

6.5.5 Tiantan Biological Recent Developments/Updates

6.6 IMBCA

6.6.1 IMBCA Company Information

6.6.2 IMBCA Description and Business Overview

6.6.3 IMBCA Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.6.4 IMBCA Poliomyelitis Vaccines Product Portfolio

6.6.5 IMBCA Recent Developments/Updates

6.7 Panacea Biotec Ltd

6.7.1 Panacea Biotec Ltd Company Information

6.7.2 Panacea Biotec Ltd Description and Business Overview

6.7.3 Panacea Biotec Ltd Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Panacea Biotec Ltd Poliomyelitis Vaccines Product Portfolio

6.7.5 Panacea Biotec Ltd Recent Developments/Updates

6.8 Bio-Med

6.8.1 Bio-Med Company Information

6.8.2 Bio-Med Description and Business Overview

6.8.3 Bio-Med Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Bio-Med Poliomyelitis Vaccines Product Portfolio

6.8.5 Bio-Med Recent Developments/Updates

6.9 Halfkin Bio-Pharmaceuticals

6.9.1 Halfkin Bio-Pharmaceuticals Company Information

6.9.2 Halfkin Bio-Pharmaceuticals Description and Business Overview

6.9.3 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product Portfolio

6.9.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Poliomyelitis Vaccines Industry Chain Analysis

7.2 Poliomyelitis Vaccines Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Poliomyelitis Vaccines Production Mode & Process Analysis

7.4 Poliomyelitis Vaccines Sales and Marketing

7.4.1 Poliomyelitis Vaccines Sales Channels

7.4.2 Poliomyelitis Vaccines Distributors

7.5 Poliomyelitis Vaccines Customer Analysis

8 Poliomyelitis Vaccines Market Dynamics

8.1 Poliomyelitis Vaccines Industry Trends

8.2 Poliomyelitis Vaccines Market Drivers

8.3 Poliomyelitis Vaccines Market Challenges

8.4 Poliomyelitis Vaccines Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Halfkin Bio-Pharmaceuticals

List of Tables

Table 1. Global Poliomyelitis Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Poliomyelitis Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Poliomyelitis Vaccines Market Competitive Situation by Manufacturers in 2024

Table 4. Global Poliomyelitis Vaccines Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Poliomyelitis Vaccines Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Poliomyelitis Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Poliomyelitis Vaccines Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Poliomyelitis Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Poliomyelitis Vaccines, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Poliomyelitis Vaccines, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Poliomyelitis Vaccines, Product Type & Application

Table 12. Global Key Manufacturers of Poliomyelitis Vaccines, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Poliomyelitis Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliomyelitis Vaccines as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Poliomyelitis Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Poliomyelitis Vaccines Sales by Region (2020-2025) & (K Units)

Table 18. Global Poliomyelitis Vaccines Sales Market Share by Region (2020-2025)

Table 19. Global Poliomyelitis Vaccines Sales by Region (2026-2031) & (K Units)

Table 20. Global Poliomyelitis Vaccines Sales Market Share by Region (2026-2031)

Table 21. Global Poliomyelitis Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Poliomyelitis Vaccines Revenue Market Share by Region (2020-2025)

Table 23. Global Poliomyelitis Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Poliomyelitis Vaccines Revenue Market Share by Region (2026-2031)

Table 25. North America Poliomyelitis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Poliomyelitis Vaccines Sales by Country (2020-2025) & (K Units)

Table 27. North America Poliomyelitis Vaccines Sales by Country (2026-2031) & (K Units)

Table 28. North America Poliomyelitis Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Poliomyelitis Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Poliomyelitis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Poliomyelitis Vaccines Sales by Country (2020-2025) & (K Units)

Table 32. Europe Poliomyelitis Vaccines Sales by Country (2026-2031) & (K Units)

Table 33. Europe Poliomyelitis Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Poliomyelitis Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Poliomyelitis Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Poliomyelitis Vaccines Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Poliomyelitis Vaccines Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Poliomyelitis Vaccines Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Poliomyelitis Vaccines Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Poliomyelitis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Poliomyelitis Vaccines Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Poliomyelitis Vaccines Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Poliomyelitis Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Poliomyelitis Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Poliomyelitis Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Poliomyelitis Vaccines Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Poliomyelitis Vaccines Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Poliomyelitis Vaccines Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Poliomyelitis Vaccines Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Poliomyelitis Vaccines Sales (K Units) by Type (2020-2025)

Table 51. Global Poliomyelitis Vaccines Sales (K Units) by Type (2026-2031)

Table 52. Global Poliomyelitis Vaccines Sales Market Share by Type (2020-2025)

Table 53. Global Poliomyelitis Vaccines Sales Market Share by Type (2026-2031)

Table 54. Global Poliomyelitis Vaccines Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Poliomyelitis Vaccines Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Poliomyelitis Vaccines Revenue Market Share by Type (2020-2025)

Table 57. Global Poliomyelitis Vaccines Revenue Market Share by Type (2026-2031)

Table 58. Global Poliomyelitis Vaccines Price (USD/Unit) by Type (2020-2025)

Table 59. Global Poliomyelitis Vaccines Price (USD/Unit) by Type (2026-2031)

Table 60. Global Poliomyelitis Vaccines Sales (K Units) by Application (2020-2025)

Table 61. Global Poliomyelitis Vaccines Sales (K Units) by Application (2026-2031)

Table 62. Global Poliomyelitis Vaccines Sales Market Share by Application (2020-2025)

Table 63. Global Poliomyelitis Vaccines Sales Market Share by Application (2026-2031)

Table 64. Global Poliomyelitis Vaccines Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Poliomyelitis Vaccines Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Poliomyelitis Vaccines Revenue Market Share by Application (2020-2025)

Table 67. Global Poliomyelitis Vaccines Revenue Market Share by Application (2026-2031)

Table 68. Global Poliomyelitis Vaccines Price (USD/Unit) by Application (2020-2025)

Table 69. Global Poliomyelitis Vaccines Price (USD/Unit) by Application (2026-2031)

Table 70. Sanofi Company Information

Table 71. Sanofi Description and Business Overview

Table 72. Sanofi Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Sanofi Poliomyelitis Vaccines Product

Table 74. Sanofi Recent Developments/Updates

Table 75. GSK Company Information

Table 76. GSK Description and Business Overview

Table 77. GSK Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. GSK Poliomyelitis Vaccines Product

Table 79. GSK Recent Developments/Updates

Table 80. Bibcol Company Information

Table 81. Bibcol Description and Business Overview

Table 82. Bibcol Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Bibcol Poliomyelitis Vaccines Product

Table 84. Bibcol Recent Developments/Updates

Table 85. Serum Institute Company Information

Table 86. Serum Institute Description and Business Overview

Table 87. Serum Institute Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Serum Institute Poliomyelitis Vaccines Product

Table 89. Serum Institute Recent Developments/Updates

Table 90. Tiantan Biological Company Information

Table 91. Tiantan Biological Description and Business Overview

Table 92. Tiantan Biological Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Tiantan Biological Poliomyelitis Vaccines Product

Table 94. Tiantan Biological Recent Developments/Updates

Table 95. IMBCA Company Information

Table 96. IMBCA Description and Business Overview

Table 97. IMBCA Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. IMBCA Poliomyelitis Vaccines Product

Table 99. IMBCA Recent Developments/Updates

Table 100. Panacea Biotec Ltd Company Information

Table 101. Panacea Biotec Ltd Description and Business Overview

Table 102. Panacea Biotec Ltd Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Panacea Biotec Ltd Poliomyelitis Vaccines Product

Table 104. Panacea Biotec Ltd Recent Developments/Updates

Table 105. Bio-Med Company Information

Table 106. Bio-Med Description and Business Overview

Table 107. Bio-Med Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Bio-Med Poliomyelitis Vaccines Product

Table 109. Bio-Med Recent Developments/Updates

Table 110. Halfkin Bio-Pharmaceuticals Company Information

Table 111. Halfkin Bio-Pharmaceuticals Description and Business Overview

Table 112. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Halfkin Bio-Pharmaceuticals Poliomyelitis Vaccines Product

Table 114. Halfkin Bio-Pharmaceuticals Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Poliomyelitis Vaccines Distributors List

Table 118. Poliomyelitis Vaccines Customers List

Table 119. Poliomyelitis Vaccines Market Trends

Table 120. Poliomyelitis Vaccines Market Drivers

Table 121. Poliomyelitis Vaccines Market Challenges

Table 122. Poliomyelitis Vaccines Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Poliomyelitis Vaccines

Figure 2. Global Poliomyelitis Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Poliomyelitis Vaccines Market Share by Type: 2024 & 2031

Figure 4. IPV Product Picture

Figure 5. OPV Product Picture

Figure 6. Global Poliomyelitis Vaccines Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Poliomyelitis Vaccines Market Share by Application: 2024 & 2031

Figure 8. Research & Academic Laboratories

Figure 9. Pharmaceutical & Biotechnology Companies

Figure 10. Others

Figure 11. Global Poliomyelitis Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Poliomyelitis Vaccines Market Size (2020-2031) & (US$ Million)

Figure 13. Global Poliomyelitis Vaccines Sales (2020-2031) & (K Units)

Figure 14. Global Poliomyelitis Vaccines Average Price (USD/Unit) & (2020-2031)

Figure 15. Poliomyelitis Vaccines Report Years Considered

Figure 16. Poliomyelitis Vaccines Sales Share by Manufacturers in 2024

Figure 17. Global Poliomyelitis Vaccines Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Poliomyelitis Vaccines Players: Market Share by Revenue in Poliomyelitis Vaccines in 2024

Figure 19. Poliomyelitis Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Poliomyelitis Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Poliomyelitis Vaccines Sales Market Share by Country (2020-2031)

Figure 22. North America Poliomyelitis Vaccines Revenue Market Share by Country (2020-2031)

Figure 23. U.S. Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Poliomyelitis Vaccines Sales Market Share by Country (2020-2031)

Figure 26. Europe Poliomyelitis Vaccines Revenue Market Share by Country (2020-2031)

Figure 27. Germany Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Poliomyelitis Vaccines Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Poliomyelitis Vaccines Revenue Market Share by Region (2020-2031)

Figure 34. China Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Poliomyelitis Vaccines Sales Market Share by Country (2020-2031)

Figure 44. Latin America Poliomyelitis Vaccines Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Poliomyelitis Vaccines Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Poliomyelitis Vaccines Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Poliomyelitis Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Poliomyelitis Vaccines by Type (2020-2031)

Figure 54. Global Revenue Market Share of Poliomyelitis Vaccines by Type (2020-2031)

Figure 55. Global Poliomyelitis Vaccines Price (USD/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Poliomyelitis Vaccines by Application (2020-2031)

Figure 57. Global Revenue Market Share of Poliomyelitis Vaccines by Application (2020-2031)

Figure 58. Global Poliomyelitis Vaccines Price (USD/Unit) by Application (2020-2031)

Figure 59. Poliomyelitis Vaccines Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions